TrialCancer chemotherapy and pharmacology2009

A multi-center phase II study of oxaliplatin, irinotecan, and capecitabine in advanced gastric/gastroesophageal junction carcinoma.

Joanna M Brell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.